Advertisement

Index by author

September 01, 1979; Volume 16,Issue 2

A

  1. ALBUQUERQUE, E. X.

    1. Mode of Action of Quinacrine on the Acetylcholine Receptor Ionic Channel Complex
      M.-C. TSAI, A. C. OLIVEIRA, E. X. ALBUQUERQUE, M. E. ELDEFRAWI and A. T. ELDEFRAWI
      Molecular Pharmacology September 1979, 16 (2) 382-392;

B

  1. BARRY, C. DAVID

    1. Molecular Requirements for Recognition at a Glucoreceptor for Insulin Release
      DANIEL C. WEAVER, C. DAVID BARRY, MICHAEL L. MCDANIEL, GARLAND R. MARSHALL and PAUL E. LACY
      Molecular Pharmacology September 1979, 16 (2) 361-368;

  2. BATZRI, SHMUEL

    1. Action of Histamine on Cyclic AMP in Guinea Pig Gastric Cells: Inhibition by H1- and H2-Receptor Antagonists
      SHMUEL BATZRI and JERRY D. GARDNER
      Molecular Pharmacology September 1979, 16 (2) 406-416;

  3. BERENBEIM, DAVID M.

    1. Regulation of Synthesis and Degradation of Rat Adrenal Phenylethanolamine N-methyltransferase
      DAVID M. BERENBEIM, DONA L. WONG, STEVEN J. MASOVER and ROLAND D. CIARANELLO
      Molecular Pharmacology September 1979, 16 (2) 482-490;
    2. Regulation of Synthesis and Degradation of Rat Adrenal Phenylethanolamine N-methyltransferase
      STEVEN J. MASOVER, DAVID M. BERENBEIM and ROLAND D. CIARANELLO
      Molecular Pharmacology September 1979, 16 (2) 491-503;

  4. BLAUSTEIN, M. P.

    1. The Effects of Some Organic "Calcium Antagonists" on Calcium Influx in Presynaptic Nerve Terminals
      D. A. NACHSHEN and M. P. BLAUSTEIN
      Molecular Pharmacology September 1979, 16 (2) 579-586;

  5. BROWN, OLIVER E.

    1. Deoxyuridine Incorporation as a Useful Measure of Methotrexate and Metoprine Uptake and Metabolic Effectiveness
      W. DAVID SEDWICK, MARY JO FYFE, OLIVER E. BROWN, THOMAS A. FRAZER, MARC KUTLER and JOHN LASZLO
      Molecular Pharmacology September 1979, 16 (2) 607-613;

  6. BÜCKER, M.

    1. The Epoxide Hydratase Inducer Trans-Stilbene Oxide Shifts the Metabolic Epoxidation of Benzo(a)pyrene from the Bay- to the K-Region and Reduces Its Mutagenicity
      M. BÜCKER, M. GOLAN, H. U. SCHMASSMANN, H. R. GLATT, P. STASIECKI and F. OESCH
      Molecular Pharmacology September 1979, 16 (2) 656-666;

C

  1. CAHILL, ANNE L.

    1. Active Transport of Methadone in Synaptosomes
      ANNE L. CAHILL, MARK P. HOORNSTRA and FEDOR MEDZIHRADSKY
      Molecular Pharmacology September 1979, 16 (2) 587-600;

  2. CALLINGHAM, BRIAN A.

    1. The Inhibition of Rat Heart Type A Monoamine Oxidase by Clorgyline as a Method for the Estimation of Enzyme Active Centers
      CHRISTOPHER J. FOWLER and BRIAN A. CALLINGHAM
      Molecular Pharmacology September 1979, 16 (2) 546-555;

  3. CHO, JUNG SOOK

    1. Physicochemical Basis of Opiate-Cerebroside Sulfate Interaction and Its Application to Receptor Theory
      TAE MOOK CHO, JUNG SOOK CHO and HORACE H. LOH
      Molecular Pharmacology September 1979, 16 (2) 393-405;

  4. CHO, TAE MOOK

    1. Physicochemical Basis of Opiate-Cerebroside Sulfate Interaction and Its Application to Receptor Theory
      TAE MOOK CHO, JUNG SOOK CHO and HORACE H. LOH
      Molecular Pharmacology September 1979, 16 (2) 393-405;

  5. CIARANELLO, ROLAND D.

    1. Regulation of Synthesis and Degradation of Rat Adrenal Phenylethanolamine N-methyltransferase
      DAVID M. BERENBEIM, DONA L. WONG, STEVEN J. MASOVER and ROLAND D. CIARANELLO
      Molecular Pharmacology September 1979, 16 (2) 482-490;
    2. Regulation of Synthesis and Degradation of Rat Adrenal Phenylethanolamine N-methyltransferase
      STEVEN J. MASOVER, DAVID M. BERENBEIM and ROLAND D. CIARANELLO
      Molecular Pharmacology September 1979, 16 (2) 491-503;

  6. CONNEY, A. H.

    1. The Highly Tumorigenic 3,4-Dihydrodiol Is a Principal Metabolite Formed from Dibenzo[a,h]anthracene by Liver Enzymes
      M. NORDQVIST, D. R. THAKKER, W. LEVIN, H. YAGI, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
      Molecular Pharmacology September 1979, 16 (2) 643-655;

  7. CROOKE, STANLEY T.

    1. DNA Binding Studies on Several New Anthracycline Antitumor Antibiotics II. The Importance of the Carbomethoxy-group at Position-10 of the Class II Anthracycline Molecule
      VIRGIL H. DUVERNAY, JONATHAN A. PACHTER and STANLEY T. CROOKE
      Molecular Pharmacology September 1979, 16 (2) 623-632;

D

  1. DEFEO, D.

    1. Effects of Phorbol Ester Tumor Promoters on Arachidonic Acid Metabolism in Chick Embryo Fibroblasts
      R. A. MUFSON, D. DEFEO and I. B. WEINSTEIN
      Molecular Pharmacology September 1979, 16 (2) 569-578;

  2. DRUMMOND, GEORGE I.

    1. Adenylate Cyclase in Cerebral Microvessels: Action of Guanine Nucleotides, Adenosine, and other Agonists
      MINTA HUANG and GEORGE I. DRUMMOND
      Molecular Pharmacology September 1979, 16 (2) 462-472;

  3. DUVERNAY, VIRGIL H.

    1. DNA Binding Studies on Several New Anthracycline Antitumor Antibiotics II. The Importance of the Carbomethoxy-group at Position-10 of the Class II Anthracycline Molecule
      VIRGIL H. DUVERNAY, JONATHAN A. PACHTER and STANLEY T. CROOKE
      Molecular Pharmacology September 1979, 16 (2) 623-632;

E

  1. ELDEFRAWI, A. T.

    1. Mode of Action of Quinacrine on the Acetylcholine Receptor Ionic Channel Complex
      M.-C. TSAI, A. C. OLIVEIRA, E. X. ALBUQUERQUE, M. E. ELDEFRAWI and A. T. ELDEFRAWI
      Molecular Pharmacology September 1979, 16 (2) 382-392;

  2. ELDEFRAWI, M. E.

    1. Mode of Action of Quinacrine on the Acetylcholine Receptor Ionic Channel Complex
      M.-C. TSAI, A. C. OLIVEIRA, E. X. ALBUQUERQUE, M. E. ELDEFRAWI and A. T. ELDEFRAWI
      Molecular Pharmacology September 1979, 16 (2) 382-392;

F

  1. FERRELL, JAMES E.

    1. Structure/Activity Studies of Flavonoids As Inhibitors of Cyclic AMP Phosphodiesterase and Relationship to Quantum Chemical Indices
      JAMES E. FERRELL, PETER D. G. CHANG SING, GILDA LOEW, ROY KING, JOAN M. MANSOUR and TAG E. MANSOUR
      Molecular Pharmacology September 1979, 16 (2) 556-568;

  2. FINKELSTEIN, ELI

    1. Spin Trapping of Superoxide
      ELI FINKELSTEIN, GERALD M. ROSEN, ELMER J. RAUCKMAN and JOHN PAXTON
      Molecular Pharmacology September 1979, 16 (2) 676-685;

  3. FOWLER, CHRISTOPHER J.

    1. The Inhibition of Rat Heart Type A Monoamine Oxidase by Clorgyline as a Method for the Estimation of Enzyme Active Centers
      CHRISTOPHER J. FOWLER and BRIAN A. CALLINGHAM
      Molecular Pharmacology September 1979, 16 (2) 546-555;

  4. FRAZER, THOMAS A.

    1. Deoxyuridine Incorporation as a Useful Measure of Methotrexate and Metoprine Uptake and Metabolic Effectiveness
      W. DAVID SEDWICK, MARY JO FYFE, OLIVER E. BROWN, THOMAS A. FRAZER, MARC KUTLER and JOHN LASZLO
      Molecular Pharmacology September 1979, 16 (2) 607-613;

  5. FRIGON, RONALD P.

    1. Human Pheochromocytoma Dopamine-Beta-Hydroxylase: Purification and Molecular Parameters of the Tetramer
      DANIEL T. O'CONNOR, RONALD P. FRIGON and RICHARD A. STONE
      Molecular Pharmacology September 1979, 16 (2) 529-538;

  6. FYFE, MARY JO

    1. Deoxyuridine Incorporation as a Useful Measure of Methotrexate and Metoprine Uptake and Metabolic Effectiveness
      W. DAVID SEDWICK, MARY JO FYFE, OLIVER E. BROWN, THOMAS A. FRAZER, MARC KUTLER and JOHN LASZLO
      Molecular Pharmacology September 1979, 16 (2) 607-613;

G

  1. GARDNER, JERRY D.

    1. Action of Histamine on Cyclic AMP in Guinea Pig Gastric Cells: Inhibition by H1- and H2-Receptor Antagonists
      SHMUEL BATZRI and JERRY D. GARDNER
      Molecular Pharmacology September 1979, 16 (2) 406-416;

  2. GLATT, H. R.

    1. The Epoxide Hydratase Inducer Trans-Stilbene Oxide Shifts the Metabolic Epoxidation of Benzo(a)pyrene from the Bay- to the K-Region and Reduces Its Mutagenicity
      M. BÜCKER, M. GOLAN, H. U. SCHMASSMANN, H. R. GLATT, P. STASIECKI and F. OESCH
      Molecular Pharmacology September 1979, 16 (2) 656-666;

  3. GOLAN, M.

    1. The Epoxide Hydratase Inducer Trans-Stilbene Oxide Shifts the Metabolic Epoxidation of Benzo(a)pyrene from the Bay- to the K-Region and Reduces Its Mutagenicity
      M. BÜCKER, M. GOLAN, H. U. SCHMASSMANN, H. R. GLATT, P. STASIECKI and F. OESCH
      Molecular Pharmacology September 1979, 16 (2) 656-666;

  4. GREEN, JACK PETER

    1. Studies on Histamine H2 Receptors Coupled to Cardiac Adenylate Cyclase
      CARL L. JOHNSON, HAREL WEINSTEIN and JACK PETER GREEN
      Molecular Pharmacology September 1979, 16 (2) 417-428;

  5. GRINDEY, GERALD B.

    1. Thymidine Induced Perturbations in Ribonucleoside and Deoxyribonucleoside Triphosphate Pools in Human Leukemic CCRF-CEM Cells
      GERALD B. GRINDEY, MING C. WANG and JAMES J. KINAHAN
      Molecular Pharmacology September 1979, 16 (2) 601-606;

H

  1. HESSE, SIGRUN

    1. Involvement of Phenolic Metabolites in the Irreversible Protein-Binding of Aromatic Hydrocarbons: Reactive Metabolites of [14C]Naphthalene and [14C]1-Naphthol Formed by Rat Liver Microsomes
      SIGRUN HESSE and MARGOT MEZGER
      Molecular Pharmacology September 1979, 16 (2) 667-675;

  2. HOORNSTRA, MARK P.

    1. Active Transport of Methadone in Synaptosomes
      ANNE L. CAHILL, MARK P. HOORNSTRA and FEDOR MEDZIHRADSKY
      Molecular Pharmacology September 1979, 16 (2) 587-600;

  3. HUANG, MINTA

    1. Adenylate Cyclase in Cerebral Microvessels: Action of Guanine Nucleotides, Adenosine, and other Agonists
      MINTA HUANG and GEORGE I. DRUMMOND
      Molecular Pharmacology September 1979, 16 (2) 462-472;

J

  1. JACKOWSKI, SUZANNE

    1. Response of Adenosine Cyclic 3',5'-Monophosphate Level in Rabbit Neutrophils to the Chemotactic Peptide Formyl-Methionyl-Leucyl-Phenylalanine
      SUZANNE JACKOWSKI and R. I. SHA'AFI
      Molecular Pharmacology September 1979, 16 (2) 473-481;

  2. JERINA, D. M.

    1. The Highly Tumorigenic 3,4-Dihydrodiol Is a Principal Metabolite Formed from Dibenzo[a,h]anthracene by Liver Enzymes
      M. NORDQVIST, D. R. THAKKER, W. LEVIN, H. YAGI, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
      Molecular Pharmacology September 1979, 16 (2) 643-655;

  3. JOHNSON, CARL L.

    1. Studies on Histamine H2 Receptors Coupled to Cardiac Adenylate Cyclase
      CARL L. JOHNSON, HAREL WEINSTEIN and JACK PETER GREEN
      Molecular Pharmacology September 1979, 16 (2) 417-428;

  4. JUNG, MICHEL J.

    1. Molecular Basis for the Irreversible Inhibition of 4-Aminobutyric Acid:2-Oxoglutarate and L-Ornithine:2-Oxoacid Aminotransferases by 3-Amino-1,5-Cyclohexadienyl Carboxylic Acid (Isogabaculine)
      BRIAN W. METCALF and MICHEL J. JUNG
      Molecular Pharmacology September 1979, 16 (2) 539-545;

K

  1. KINAHAN, JAMES J.

    1. Thymidine Induced Perturbations in Ribonucleoside and Deoxyribonucleoside Triphosphate Pools in Human Leukemic CCRF-CEM Cells
      GERALD B. GRINDEY, MING C. WANG and JAMES J. KINAHAN
      Molecular Pharmacology September 1979, 16 (2) 601-606;

  2. KING, ROY

    1. Structure/Activity Studies of Flavonoids As Inhibitors of Cyclic AMP Phosphodiesterase and Relationship to Quantum Chemical Indices
      JAMES E. FERRELL, PETER D. G. CHANG SING, GILDA LOEW, ROY KING, JOAN M. MANSOUR and TAG E. MANSOUR
      Molecular Pharmacology September 1979, 16 (2) 556-568;

  3. Kirsten, E.

    1. Molecular Toxicology of (-)-erythro-Fluorocitrate: Selective Inhibition of Citrate Transport in Mitochondria and the Binding of Fluorocitrate to Mitochondrial Proteins
      E. Kirsten, M. L. Sharma and E. Kun
      Molecular Pharmacology September 1979, 16 (2) 686;

  4. KORUDA, MARK

    1. Metabolic Activation of Polycyclic Aromatic Carcinogens: A Theoretical Study
      ROBERT S. UMANS, MARK KORUDA and D. J. SARDELLA
      Molecular Pharmacology September 1979, 16 (2) 633-642;

  5. Kun, E.

    1. Molecular Toxicology of (-)-erythro-Fluorocitrate: Selective Inhibition of Citrate Transport in Mitochondria and the Binding of Fluorocitrate to Mitochondrial Proteins
      E. Kirsten, M. L. Sharma and E. Kun
      Molecular Pharmacology September 1979, 16 (2) 686;

  6. KUTLER, MARC

    1. Deoxyuridine Incorporation as a Useful Measure of Methotrexate and Metoprine Uptake and Metabolic Effectiveness
      W. DAVID SEDWICK, MARY JO FYFE, OLIVER E. BROWN, THOMAS A. FRAZER, MARC KUTLER and JOHN LASZLO
      Molecular Pharmacology September 1979, 16 (2) 607-613;

L

  1. LACY, PAUL E.

    1. Molecular Requirements for Recognition at a Glucoreceptor for Insulin Release
      DANIEL C. WEAVER, C. DAVID BARRY, MICHAEL L. MCDANIEL, GARLAND R. MARSHALL and PAUL E. LACY
      Molecular Pharmacology September 1979, 16 (2) 361-368;

  2. LASZLO, JOHN

    1. Deoxyuridine Incorporation as a Useful Measure of Methotrexate and Metoprine Uptake and Metabolic Effectiveness
      W. DAVID SEDWICK, MARY JO FYFE, OLIVER E. BROWN, THOMAS A. FRAZER, MARC KUTLER and JOHN LASZLO
      Molecular Pharmacology September 1979, 16 (2) 607-613;

  3. LAU, CHRISTOPHER

    1. Regulation of Rat Heart Ornithine Decarboxylase: Change in Affinity for Ornithine Evoked by Neuronal, Hormonal, and Ontogenetic Stimuli
      CHRISTOPHER LAU and THEODORE A. SLOTKIN
      Molecular Pharmacology September 1979, 16 (2) 504-512;

  4. LEVIN, ROBERT M.

    1. Distribution and Function of Adrenergic Receptors in the Urinary Bladder of the Rabbit
      ROBERT M. LEVIN and ALAN J. WEIN
      Molecular Pharmacology September 1979, 16 (2) 441-448;

  5. LEVIN, W.

    1. The Highly Tumorigenic 3,4-Dihydrodiol Is a Principal Metabolite Formed from Dibenzo[a,h]anthracene by Liver Enzymes
      M. NORDQVIST, D. R. THAKKER, W. LEVIN, H. YAGI, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
      Molecular Pharmacology September 1979, 16 (2) 643-655;

  6. LOEW, GILDA

    1. Structure/Activity Studies of Flavonoids As Inhibitors of Cyclic AMP Phosphodiesterase and Relationship to Quantum Chemical Indices
      JAMES E. FERRELL, PETER D. G. CHANG SING, GILDA LOEW, ROY KING, JOAN M. MANSOUR and TAG E. MANSOUR
      Molecular Pharmacology September 1979, 16 (2) 556-568;

  7. LOH, HORACE H.

    1. Physicochemical Basis of Opiate-Cerebroside Sulfate Interaction and Its Application to Receptor Theory
      TAE MOOK CHO, JUNG SOOK CHO and HORACE H. LOH
      Molecular Pharmacology September 1979, 16 (2) 393-405;

M

  1. MANSOUR, JOAN M.

    1. Structure/Activity Studies of Flavonoids As Inhibitors of Cyclic AMP Phosphodiesterase and Relationship to Quantum Chemical Indices
      JAMES E. FERRELL, PETER D. G. CHANG SING, GILDA LOEW, ROY KING, JOAN M. MANSOUR and TAG E. MANSOUR
      Molecular Pharmacology September 1979, 16 (2) 556-568;

  2. MANSOUR, TAG E.

    1. Structure/Activity Studies of Flavonoids As Inhibitors of Cyclic AMP Phosphodiesterase and Relationship to Quantum Chemical Indices
      JAMES E. FERRELL, PETER D. G. CHANG SING, GILDA LOEW, ROY KING, JOAN M. MANSOUR and TAG E. MANSOUR
      Molecular Pharmacology September 1979, 16 (2) 556-568;

  3. MARSHALL, GARLAND R.

    1. Molecular Requirements for Recognition at a Glucoreceptor for Insulin Release
      DANIEL C. WEAVER, C. DAVID BARRY, MICHAEL L. MCDANIEL, GARLAND R. MARSHALL and PAUL E. LACY
      Molecular Pharmacology September 1979, 16 (2) 361-368;

  4. MASOVER, STEVEN J.

    1. Regulation of Synthesis and Degradation of Rat Adrenal Phenylethanolamine N-methyltransferase
      DAVID M. BERENBEIM, DONA L. WONG, STEVEN J. MASOVER and ROLAND D. CIARANELLO
      Molecular Pharmacology September 1979, 16 (2) 482-490;
    2. Regulation of Synthesis and Degradation of Rat Adrenal Phenylethanolamine N-methyltransferase
      STEVEN J. MASOVER, DAVID M. BERENBEIM and ROLAND D. CIARANELLO
      Molecular Pharmacology September 1979, 16 (2) 491-503;

  5. MASSERANO, JOSEPH M.

    1. The Rapid Activation of Adrenal Tyrosine Hydroxylase by Decapitation and its Relationship to a Cyclic AMP-dependent Phosphorylating Mechanism
      JOSEPH M. MASSERANO and NORMAN WEINER
      Molecular Pharmacology September 1979, 16 (2) 513-528;

  6. MCDANIEL, MICHAEL L.

    1. Molecular Requirements for Recognition at a Glucoreceptor for Insulin Release
      DANIEL C. WEAVER, C. DAVID BARRY, MICHAEL L. MCDANIEL, GARLAND R. MARSHALL and PAUL E. LACY
      Molecular Pharmacology September 1979, 16 (2) 361-368;

  7. MCDERMED, J. D.

    1. The Conformation of Dopamine at Its Receptor: Binding of Monohydroxy-2-aminotetralin Enantiomers and Positional Isomers
      J. L. TEDESCO, P. SEEMAN and J. D. MCDERMED
      Molecular Pharmacology September 1979, 16 (2) 369-381;

  8. MEDZIHRADSKY, FEDOR

    1. Active Transport of Methadone in Synaptosomes
      ANNE L. CAHILL, MARK P. HOORNSTRA and FEDOR MEDZIHRADSKY
      Molecular Pharmacology September 1979, 16 (2) 587-600;

  9. METCALF, BRIAN W.

    1. Molecular Basis for the Irreversible Inhibition of 4-Aminobutyric Acid:2-Oxoglutarate and L-Ornithine:2-Oxoacid Aminotransferases by 3-Amino-1,5-Cyclohexadienyl Carboxylic Acid (Isogabaculine)
      BRIAN W. METCALF and MICHEL J. JUNG
      Molecular Pharmacology September 1979, 16 (2) 539-545;

  10. MEZGER, MARGOT

    1. Involvement of Phenolic Metabolites in the Irreversible Protein-Binding of Aromatic Hydrocarbons: Reactive Metabolites of [14C]Naphthalene and [14C]1-Naphthol Formed by Rat Liver Microsomes
      SIGRUN HESSE and MARGOT MEZGER
      Molecular Pharmacology September 1979, 16 (2) 667-675;

  11. MUFSON, R. A.

    1. Effects of Phorbol Ester Tumor Promoters on Arachidonic Acid Metabolism in Chick Embryo Fibroblasts
      R. A. MUFSON, D. DEFEO and I. B. WEINSTEIN
      Molecular Pharmacology September 1979, 16 (2) 569-578;

N

  1. NACHSHEN, D. A.

    1. The Effects of Some Organic "Calcium Antagonists" on Calcium Influx in Presynaptic Nerve Terminals
      D. A. NACHSHEN and M. P. BLAUSTEIN
      Molecular Pharmacology September 1979, 16 (2) 579-586;

  2. NORDQVIST, M.

    1. The Highly Tumorigenic 3,4-Dihydrodiol Is a Principal Metabolite Formed from Dibenzo[a,h]anthracene by Liver Enzymes
      M. NORDQVIST, D. R. THAKKER, W. LEVIN, H. YAGI, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
      Molecular Pharmacology September 1979, 16 (2) 643-655;

O

  1. O'CONNOR, DANIEL T.

    1. Human Pheochromocytoma Dopamine-Beta-Hydroxylase: Purification and Molecular Parameters of the Tetramer
      DANIEL T. O'CONNOR, RONALD P. FRIGON and RICHARD A. STONE
      Molecular Pharmacology September 1979, 16 (2) 529-538;

  2. OESCH, F.

    1. The Epoxide Hydratase Inducer Trans-Stilbene Oxide Shifts the Metabolic Epoxidation of Benzo(a)pyrene from the Bay- to the K-Region and Reduces Its Mutagenicity
      M. BÜCKER, M. GOLAN, H. U. SCHMASSMANN, H. R. GLATT, P. STASIECKI and F. OESCH
      Molecular Pharmacology September 1979, 16 (2) 656-666;

  3. OLIVEIRA, A. C.

    1. Mode of Action of Quinacrine on the Acetylcholine Receptor Ionic Channel Complex
      M.-C. TSAI, A. C. OLIVEIRA, E. X. ALBUQUERQUE, M. E. ELDEFRAWI and A. T. ELDEFRAWI
      Molecular Pharmacology September 1979, 16 (2) 382-392;

P

  1. PACHTER, JONATHAN A.

    1. DNA Binding Studies on Several New Anthracycline Antitumor Antibiotics II. The Importance of the Carbomethoxy-group at Position-10 of the Class II Anthracycline Molecule
      VIRGIL H. DUVERNAY, JONATHAN A. PACHTER and STANLEY T. CROOKE
      Molecular Pharmacology September 1979, 16 (2) 623-632;

  2. PAXTON, JOHN

    1. Spin Trapping of Superoxide
      ELI FINKELSTEIN, GERALD M. ROSEN, ELMER J. RAUCKMAN and JOHN PAXTON
      Molecular Pharmacology September 1979, 16 (2) 676-685;

R

  1. RAUCKMAN, ELMER J.

    1. Spin Trapping of Superoxide
      ELI FINKELSTEIN, GERALD M. ROSEN, ELMER J. RAUCKMAN and JOHN PAXTON
      Molecular Pharmacology September 1979, 16 (2) 676-685;

  2. ROSEN, GERALD M.

    1. Spin Trapping of Superoxide
      ELI FINKELSTEIN, GERALD M. ROSEN, ELMER J. RAUCKMAN and JOHN PAXTON
      Molecular Pharmacology September 1979, 16 (2) 676-685;

  3. RYAN, D. E.

    1. The Highly Tumorigenic 3,4-Dihydrodiol Is a Principal Metabolite Formed from Dibenzo[a,h]anthracene by Liver Enzymes
      M. NORDQVIST, D. R. THAKKER, W. LEVIN, H. YAGI, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
      Molecular Pharmacology September 1979, 16 (2) 643-655;

  4. RYSER, HUGUES J.-P.

    1. Poly (L-Lysine) and Poly (D-Lysine) Conjugates of Methotrexate: Different Inhibitory Effect on Drug Resistant Cells
      WEI-CHIANG SHEN and HUGUES J.-P. RYSER
      Molecular Pharmacology September 1979, 16 (2) 614-622;

S

  1. SARDELLA, D. J.

    1. Metabolic Activation of Polycyclic Aromatic Carcinogens: A Theoretical Study
      ROBERT S. UMANS, MARK KORUDA and D. J. SARDELLA
      Molecular Pharmacology September 1979, 16 (2) 633-642;

  2. SCHMASSMANN, H. U.

    1. The Epoxide Hydratase Inducer Trans-Stilbene Oxide Shifts the Metabolic Epoxidation of Benzo(a)pyrene from the Bay- to the K-Region and Reduces Its Mutagenicity
      M. BÜCKER, M. GOLAN, H. U. SCHMASSMANN, H. R. GLATT, P. STASIECKI and F. OESCH
      Molecular Pharmacology September 1979, 16 (2) 656-666;

  3. SEDWICK, W. DAVID

    1. Deoxyuridine Incorporation as a Useful Measure of Methotrexate and Metoprine Uptake and Metabolic Effectiveness
      W. DAVID SEDWICK, MARY JO FYFE, OLIVER E. BROWN, THOMAS A. FRAZER, MARC KUTLER and JOHN LASZLO
      Molecular Pharmacology September 1979, 16 (2) 607-613;

  4. SEEMAN, P.

    1. The Conformation of Dopamine at Its Receptor: Binding of Monohydroxy-2-aminotetralin Enantiomers and Positional Isomers
      J. L. TEDESCO, P. SEEMAN and J. D. MCDERMED
      Molecular Pharmacology September 1979, 16 (2) 369-381;

  5. SHA'AFI, R. I.

    1. Response of Adenosine Cyclic 3',5'-Monophosphate Level in Rabbit Neutrophils to the Chemotactic Peptide Formyl-Methionyl-Leucyl-Phenylalanine
      SUZANNE JACKOWSKI and R. I. SHA'AFI
      Molecular Pharmacology September 1979, 16 (2) 473-481;

  6. Sharma, M. L.

    1. Molecular Toxicology of (-)-erythro-Fluorocitrate: Selective Inhibition of Citrate Transport in Mitochondria and the Binding of Fluorocitrate to Mitochondrial Proteins
      E. Kirsten, M. L. Sharma and E. Kun
      Molecular Pharmacology September 1979, 16 (2) 686;

  7. SHEN, WEI-CHIANG

    1. Poly (L-Lysine) and Poly (D-Lysine) Conjugates of Methotrexate: Different Inhibitory Effect on Drug Resistant Cells
      WEI-CHIANG SHEN and HUGUES J.-P. RYSER
      Molecular Pharmacology September 1979, 16 (2) 614-622;

  8. SING, PETER D. G. CHANG

    1. Structure/Activity Studies of Flavonoids As Inhibitors of Cyclic AMP Phosphodiesterase and Relationship to Quantum Chemical Indices
      JAMES E. FERRELL, PETER D. G. CHANG SING, GILDA LOEW, ROY KING, JOAN M. MANSOUR and TAG E. MANSOUR
      Molecular Pharmacology September 1979, 16 (2) 556-568;

  9. SLOTKIN, THEODORE A.

    1. Regulation of Rat Heart Ornithine Decarboxylase: Change in Affinity for Ornithine Evoked by Neuronal, Hormonal, and Ontogenetic Stimuli
      CHRISTOPHER LAU and THEODORE A. SLOTKIN
      Molecular Pharmacology September 1979, 16 (2) 504-512;

  10. STASIECKI, P.

    1. The Epoxide Hydratase Inducer Trans-Stilbene Oxide Shifts the Metabolic Epoxidation of Benzo(a)pyrene from the Bay- to the K-Region and Reduces Its Mutagenicity
      M. BÜCKER, M. GOLAN, H. U. SCHMASSMANN, H. R. GLATT, P. STASIECKI and F. OESCH
      Molecular Pharmacology September 1979, 16 (2) 656-666;

  11. STONE, RICHARD A.

    1. Human Pheochromocytoma Dopamine-Beta-Hydroxylase: Purification and Molecular Parameters of the Tetramer
      DANIEL T. O'CONNOR, RONALD P. FRIGON and RICHARD A. STONE
      Molecular Pharmacology September 1979, 16 (2) 529-538;

T

  1. TEDESCO, J. L.

    1. The Conformation of Dopamine at Its Receptor: Binding of Monohydroxy-2-aminotetralin Enantiomers and Positional Isomers
      J. L. TEDESCO, P. SEEMAN and J. D. MCDERMED
      Molecular Pharmacology September 1979, 16 (2) 369-381;

  2. THAKKER, D. R.

    1. The Highly Tumorigenic 3,4-Dihydrodiol Is a Principal Metabolite Formed from Dibenzo[a,h]anthracene by Liver Enzymes
      M. NORDQVIST, D. R. THAKKER, W. LEVIN, H. YAGI, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
      Molecular Pharmacology September 1979, 16 (2) 643-655;

  3. THOMAS, P. E.

    1. The Highly Tumorigenic 3,4-Dihydrodiol Is a Principal Metabolite Formed from Dibenzo[a,h]anthracene by Liver Enzymes
      M. NORDQVIST, D. R. THAKKER, W. LEVIN, H. YAGI, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
      Molecular Pharmacology September 1979, 16 (2) 643-655;

  4. TSAI, M.-C.

    1. Mode of Action of Quinacrine on the Acetylcholine Receptor Ionic Channel Complex
      M.-C. TSAI, A. C. OLIVEIRA, E. X. ALBUQUERQUE, M. E. ELDEFRAWI and A. T. ELDEFRAWI
      Molecular Pharmacology September 1979, 16 (2) 382-392;

U

  1. UMANS, ROBERT S.

    1. Metabolic Activation of Polycyclic Aromatic Carcinogens: A Theoretical Study
      ROBERT S. UMANS, MARK KORUDA and D. J. SARDELLA
      Molecular Pharmacology September 1979, 16 (2) 633-642;

V

  1. VENTER, J. CRAIG

    1. High Efficiency Coupling Between Beta-adrenergic Receptors and Cardiac Contractility: Direct Evidence for "Spare" Beta-adrenergic Receptors
      J. CRAIG VENTER
      Molecular Pharmacology September 1979, 16 (2) 429-440;

W

  1. WANG, MING C.

    1. Thymidine Induced Perturbations in Ribonucleoside and Deoxyribonucleoside Triphosphate Pools in Human Leukemic CCRF-CEM Cells
      GERALD B. GRINDEY, MING C. WANG and JAMES J. KINAHAN
      Molecular Pharmacology September 1979, 16 (2) 601-606;

  2. WEAVER, DANIEL C.

    1. Molecular Requirements for Recognition at a Glucoreceptor for Insulin Release
      DANIEL C. WEAVER, C. DAVID BARRY, MICHAEL L. MCDANIEL, GARLAND R. MARSHALL and PAUL E. LACY
      Molecular Pharmacology September 1979, 16 (2) 361-368;

  3. WEIN, ALAN J.

    1. Distribution and Function of Adrenergic Receptors in the Urinary Bladder of the Rabbit
      ROBERT M. LEVIN and ALAN J. WEIN
      Molecular Pharmacology September 1979, 16 (2) 441-448;

  4. WEINER, NORMAN

    1. The Rapid Activation of Adrenal Tyrosine Hydroxylase by Decapitation and its Relationship to a Cyclic AMP-dependent Phosphorylating Mechanism
      JOSEPH M. MASSERANO and NORMAN WEINER
      Molecular Pharmacology September 1979, 16 (2) 513-528;

  5. WEINSTEIN, HAREL

    1. Studies on Histamine H2 Receptors Coupled to Cardiac Adenylate Cyclase
      CARL L. JOHNSON, HAREL WEINSTEIN and JACK PETER GREEN
      Molecular Pharmacology September 1979, 16 (2) 417-428;

  6. WEINSTEIN, I. B.

    1. Effects of Phorbol Ester Tumor Promoters on Arachidonic Acid Metabolism in Chick Embryo Fibroblasts
      R. A. MUFSON, D. DEFEO and I. B. WEINSTEIN
      Molecular Pharmacology September 1979, 16 (2) 569-578;

  7. WICKS, WESLEY D.

    1. Coordinate Protein Kinase Activation and Specific Enzyme Induction by Cyclic Nucleotide Derivatives in Intact Cultured Hepatoma Cells
      JAYANTHA WIMALASENA and WESLEY D. WICKS
      Molecular Pharmacology September 1979, 16 (2) 449-461;

  8. WIMALASENA, JAYANTHA

    1. Coordinate Protein Kinase Activation and Specific Enzyme Induction by Cyclic Nucleotide Derivatives in Intact Cultured Hepatoma Cells
      JAYANTHA WIMALASENA and WESLEY D. WICKS
      Molecular Pharmacology September 1979, 16 (2) 449-461;

  9. WONG, DONA L.

    1. Regulation of Synthesis and Degradation of Rat Adrenal Phenylethanolamine N-methyltransferase
      DAVID M. BERENBEIM, DONA L. WONG, STEVEN J. MASOVER and ROLAND D. CIARANELLO
      Molecular Pharmacology September 1979, 16 (2) 482-490;

Y

  1. YAGI, H.

    1. The Highly Tumorigenic 3,4-Dihydrodiol Is a Principal Metabolite Formed from Dibenzo[a,h]anthracene by Liver Enzymes
      M. NORDQVIST, D. R. THAKKER, W. LEVIN, H. YAGI, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
      Molecular Pharmacology September 1979, 16 (2) 643-655;
Back to top

In this issue